Related Experiment Videos
Intravenous immunoglobulin therapy for chronic inflammatory demyelinating polyneuropathy recalcitrant to conventional
K Urval1, R P Nelson, S R Cohen
1Department of Pediatrics, University of South Florida, St. Petersburg.
Chronic idiopathic demyelinating polyneuropathy is an immunologically mediated disorder that may not respond to glucocorticoid therapy, cytotoxic or other immunosuppressive medications, or plasmapheresis. We have reported such a case in which the patient had sustained clinical improvement with the repeated administration of high doses of intravenous immunoglobulin.
Chronic idiopathic demyelinating polyneuropathy is an immunologically mediated disorder that may not respond to glucocorticoid therapy, cytotoxic or other immunosuppressive medications, or plasmapheresis. We have reported such a case in which the patient had sustained clinical improvement with the repeated administration of high doses of intravenous immunoglobulin.